2X-121 Uses, Dosage, Side Effects and more
2X-121 is under investigation in clinical trial NCT03562832 (Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP).
Trade Name | 2X-121 |
Generic | 2X-121 |
Type | |
Formula | C18H15N5O |
Weight | Average: 317.352 Monoisotopic: 317.127660123 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |